Trillium Eye Care Pre-IPO

South East, USA

Short Summary

Join this international health care group expand clinics in North America. Convertible Note pays 10% interest which converts into Stock pre-IPO. Company is targeting an IPO in the US at 5X Return to Investors.

Overview

Target
US$1,500,000
Minimum
US$5,000
Investment Raised
US$100,000
Previous Rounds N/A
Stage Profitable
Investor Role

Highlights

  • A Pre-IPO Healthcare Company with Significant Growth Potential
  • 10% Return on Invested Capital; Convertible into Stock
  • Company is targeting stock listing in the US
  • Diversified operations in US and Canada
  • A stable and recession-proof industry - 94% businesses profitable per stats
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

0% raised

3 Cryotherapy Locations

location_on North East, USA

The business is whole body cryotherapy & cryo slimming centre based in New Jersey. With 3 locations, we're looking for seed capital to expand our growth to other nearby markets. Our business tailors to both the health/fitness & the beauty market

US$ 350,000

Target

US$ 50,000

Min per Investor

Global Pro
0% raised

Greensburg Spa

location_on Midwest, USA

To provide a clean, relaxing, holistic spa that a person can go to and achieve relaxation while helping to alleviate the pain, muscle stiffness, breathing and any other health ailment they are experiencing.

US$ 300,000

Target

US$ 300,000

Min per Investor

Global Pro
0% raised

CBD PRODUCT-PATENTED

location_on South West, USA

CBD for E.D. (erectile dysfunction) is a first to market, infused product. This is a $2 billion market in the U.S., $7.5 billion world wide.

US$ 100,000

Target

US$ 10,000

Min per Investor

load one similar proposal